Synthego Stock
Genome Engineering Solutions
Sign up today and learn more about Synthego Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Synthego Stock
Synthego is a provider of genome engineering solutions. The company offers CRISPR kits, such as the CRISPR evolution, a portfolio of synthetic RNA designed for CRISPR genome editing and research. Synthego claims that its CRISPR genome engineering technology enables scientists to easily and precisely edit the DNA of any genome. Select applications of gene editing include pathway analysis, stem cells, and diagnostics. The company also offers two products: CRISPR-edited iPS cells and Engineered Cells.
The company is headquartered in Redwood City, CA, and was founded in July 2012. Notable investors include Founders Fund, 8VC, and Menlo Ventures.
Investors
8VC
Anduril Industries, Sila Nanotechnologies, Cityblock Health, project44, Blend, Aspiration, Addepar, Illumio, BlueVoyant, Guardant Health
Alexandria Venture
Arab Angel Fund
Founders Fund
Lyft, Spotify, Airbnb, Stripe, Anduril Industries, Flexport, Palantir Technologies, Wish, Compass, Zenefits
Intel Capital
One97, DataRobot, SambaNova Systems, DocuSign, Joby Aviation, MongoDB, Sprinklr, Synthego, Vectra, SiFive
Menlo Ventures
Uber, Chime, Machine Zone, Getaround, BitSight, Recursion Pharmaceuticals, Outreach, Benchling, Synthego, Abnormal Security
SciFi VC
Zymergen, PsiQuantum, Anchorage Digital, Synthego, Virta Health, Emulate
ZhenFund
Bolt Financial, Synthego, The Minerva Project, Artsy, Osaro, Stratifyd
Funding History
| June 2013 | $8.3M |
|---|---|
| December 2016 | $4.4M |
| December 2016 | $41.9M |
| October 2018 | $116M |
| June 2020 | $100M |
| December 2021 | $144M |
Management
Chief Executive Officer
Paul Dabrowski
Chief Financial Officer
Avi Raval
Press
mass-spec-capital - Sep, 12 2023
Synthego Corporation. (5/17/23). "Press Release: Synthego Announces Invalidation of Agilent Patents in CRISPR Dispute". Redwood City, CA.genengnews - Aug, 25 2023
Synthego, bit.bio Collaborate on Multiplexed Cell Engineering Platformprnewswire - May, 17 2023
Synthego Announces Invalidation of Agilent Patents in CRISPR Disputeaithority - Apr, 8 2023
Synthego Launches Express Cell Pools for Faster, More Efficient Genome Editingprnewswire - Mar, 17 2023
Synthego Introduces CRISPR Discovery Partners to Streamline CRISPR-Driven Drug Discovery Researchtrib - Dec, 1 2022
Redwood City biotech company Synthego to cut 20% of staffbiospace - Sep, 22 2022
Calibr, Synthego, BlueSphere and More Showcase Data at CAR-TCR Summitendpts - Jul, 28 2022
After netting $200M, Synthego to break ground on its manufacturing facilitynews - Feb, 18 2022
The Week’s 10 Biggest Funding Rounds: Securonix Secures $1B Round, Uniphore Nabs $400M For Better Customer Servicebizjournals - Feb, 18 2022
Redwood City biotech Synthego raises $200M as it develops gene-editing toolbiospace - Feb, 17 2022
Synthego Scores $200M to Advance CRISPR “Science at Scale”endpts - Feb, 17 2022
With $200M in new cash, Synthego wants to become the manufacturing bedrock for CRISPR. But where are its customers?genomeweb - Oct, 6 2021
Synthego Preemptively Sues Agilent Technologies to Ward Off CRISPR Patent Infringement AllegationsBenzinga - Oct, 15 2020
Synthego's CRISPR Platform Enables Faster Identification of Potential Coronavirus Treatmentzpr - Sep, 3 2020
Synthego raises $100 million for AI-driven gene editinggoo - Aug, 28 2020
Synthego Raises $100M in Series D Fundingzpr - Aug, 26 2020
Synthego Raises $100 Million to Accelerate CRISPR Platform Scale-up in Response to Growing Demandaxial - Mar, 23 2020
Case study on Synthegonews-medical - Jan, 25 2020
Synthego adopts good manufacturing practices for highest-quality genome engineering for clinical applicationsPR Newswire - Jan, 14 2020
Synthego Adopts Good Manufacturing Practices for Highest-Quality Genome Engineering for Clinical Applicationsgenomeweb - Oct, 26 2019
New Products Posted to GenomeWeb: Biocartis, Synthego, Sophia Geneticssynbiobeta - Oct, 23 2019
Synthego Launches High-Throughput Induced Pluripotent Stem Cell Genome Engineeringbioportfolio - Oct, 23 2019
New Synthego Program Provides Unprecedented Editing of iPS http://dlvr.it/RGl6rk pic.twitter.com/IEzHC73qkPprnewswire - Jun, 4 2019
Synthego Introduces the Next Generation of CRISPR Knockout Technology with the Gene Knockout Kit v2pehub - Oct, 26 2018
Synthego nets $110 mln Series Cwired - May, 3 2018
Biology Will Be the Next Great Computing PlatformEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
